<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6543446</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">30935858</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6543446</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">S2213-1582(19)30146-9</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.nicl.2019.101796</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">101796</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>HAM-D items used in the original study and best-matched IDS items used in this study.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0005"><label>Table 1</label><caption><p>HAM-D items used in the original study and best-matched IDS items used in this study.</p></caption><alt-text id="al0020">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>HAMD item</th><th>IDS item</th></tr></thead><tbody><tr><td>Mood</td><td>Feeling sad</td></tr><tr><td>Guilt</td><td>Self criticism and blame</td></tr><tr><td>Suicide</td><td>Thoughts of death or suicide</td></tr><tr><td>Early insomnia</td><td>Early insomnia</td></tr><tr><td>Mid insomnia</td><td>Mid insomnia</td></tr><tr><td>Late insomnia</td><td>Late insomnia</td></tr><tr><td>Anhedonia</td><td>Capacity for pleasure or enjoyment (excluding sex)</td></tr><tr><td>Retardation</td><td>Psychomotor retardation</td></tr><tr><td>Agitation</td><td>Psychomotor agitation</td></tr><tr><td>Anxiety psychological</td><td>Feeling anxious or tense</td></tr><tr><td>Anxiety physiological</td><td>Other bodily symptoms/sympathetic arousal</td></tr><tr><td>Somatic gastro-internal</td><td>Gastrointestinal complaints</td></tr><tr><td>Fatigue/aches/low energy</td><td>Energy level/fatiguability</td></tr><tr><td>Genital</td><td>Interest in sex</td></tr><tr><td>Hypochondria</td><td>Somatic complains</td></tr><tr><td>Weight loss</td><td>Weight loss</td></tr><tr><td>Insight</td><td>Sensitivity</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">HAM-D items used in the original study and best-matched IDS items used in this study.</div>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>HAMD item</th><th>IDS item</th></tr></thead><tbody><tr><td>Mood</td><td>Feeling sad</td></tr><tr><td>Guilt</td><td>Self criticism and blame</td></tr><tr><td>Suicide</td><td>Thoughts of death or suicide</td></tr><tr><td>Early insomnia</td><td>Early insomnia</td></tr><tr><td>Mid insomnia</td><td>Mid insomnia</td></tr><tr><td>Late insomnia</td><td>Late insomnia</td></tr><tr><td>Anhedonia</td><td>Capacity for pleasure or enjoyment (excluding sex)</td></tr><tr><td>Retardation</td><td>Psychomotor retardation</td></tr><tr><td>Agitation</td><td>Psychomotor agitation</td></tr><tr><td>Anxiety psychological</td><td>Feeling anxious or tense</td></tr><tr><td>Anxiety physiological</td><td>Other bodily symptoms/sympathetic arousal</td></tr><tr><td>Somatic gastro-internal</td><td>Gastrointestinal complaints</td></tr><tr><td>Fatigue/aches/low energy</td><td>Energy level/fatiguability</td></tr><tr><td>Genital</td><td>Interest in sex</td></tr><tr><td>Hypochondria</td><td>Somatic complains</td></tr><tr><td>Weight loss</td><td>Weight loss</td></tr><tr><td>Insight</td><td>Sensitivity</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>t0010</table-id><table-label>Table 2</table-label><table-caption>Sample characteristics for the NESDA (stratified by study site) and MOTAR samples.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0010"><label>Table 2</label><caption><p>Sample characteristics for the NESDA (stratified by study site) and MOTAR samples.</p></caption><alt-text id="al0025">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th/><th>NESDA 1</th><th>NESDA 2</th><th>NESDA 3</th><th>MOTAR</th><th>Total</th></tr></thead><tbody><tr><td>N</td><td>32</td><td>57</td><td>62</td><td>36</td><td>187</td></tr><tr><td>Age (SD)</td><td>36 (9.52)</td><td>37.26 (10.26)</td><td>35.87 (11.51)</td><td>36.69 (12.37)</td><td>36.48 (10.93)</td></tr><tr><td>N Female (%)</td><td>19 (59%)</td><td>39 (68%)</td><td>43 (69%)</td><td>23 (66%)</td><td>124 (66%)</td></tr><tr><td>N MDD (%) (no anx. disorder)</td><td>13 (40%)</td><td>18 (32%)</td><td>22 (35%)</td><td>10 (28%)</td><td>63 (34%)</td></tr><tr><td>N Anxiety disorder (%) (no MDD)</td><td>11 (34%)</td><td>13 (22%)</td><td>21 (34%)</td><td>2 (6%)</td><td>47 (25%)</td></tr><tr><td>N Comorbid (%)</td><td>8 (25%)</td><td>26 (45%)</td><td>19 (30%)</td><td>24 (67%)</td><td>77 (41%)</td></tr><tr><td>Current<xref rid="tf0005" ref-type="table-fn">⁎</xref> IDS (SD)</td><td>22.31 (9.66)</td><td>24.66 (11.45)</td><td>19.93 (12.42)</td><td>15.81 (10.56)</td><td>21.11 (11.96)</td></tr><tr><td>Current<xref rid="tf0005" ref-type="table-fn">⁎</xref> IDS categorical none/mild/moderate/severe/very severe</td><td>5/16/9/1/1</td><td>10/18/22/6/1</td><td>22/20/16/2/2</td><td>19/10/5/2/0</td><td>56/64/52/11/4</td></tr><tr><td>Current<xref rid="tf0005" ref-type="table-fn">⁎</xref> BAI (SD)</td><td>13.19 (8.45)</td><td>13.33 (9.73)</td><td>13.34 (9.35)</td><td>21.67 (11.95)</td><td>14.91 (10.34)</td></tr><tr><td>Current<xref rid="tf0005" ref-type="table-fn">⁎</xref> BAI categorical none/mild/moderate/severe</td><td>11/3/7/1</td><td>22/19/13/3</td><td>27/18/12/5</td><td>5/11/11/9</td><td>65/61/43/18</td></tr><tr><td>N in remission (IDS and BAI)</td><td>3 (9%)</td><td>10 (18%)</td><td>16 (25%)</td><td>5 (14%)</td><td>34 (18%)</td></tr><tr><td>Baseline antidepressant use</td><td>7 (21%)</td><td>20 (35%)</td><td>23 (37%)</td><td>0 (0%)</td><td>50 (26%)</td></tr><tr><td>Social phobia</td><td>12 (37%)</td><td>23 (40%)</td><td>23 (37%)</td><td>15 (42%)</td><td>73 (39%)</td></tr><tr><td>Panic with agoraphobia</td><td>6 (18%)</td><td>13 (22%)</td><td>17 (27%)</td><td>8 (22%)</td><td>44 (24%)</td></tr><tr><td>Panic without agoraphobia</td><td>4 (13%)</td><td>11 (19%)</td><td>9 (15%)</td><td>1 (3%)</td><td>25 (13%)</td></tr><tr><td>Agoraphobia</td><td>4 (13%)</td><td>3 (5%)</td><td>3 (5%)</td><td>0 (0%)</td><td>10 (5%)</td></tr><tr><td>GAD</td><td>7 (22%)</td><td>16 (28%)</td><td>15 (24%)</td><td>7 (19%)</td><td>45 (24%)</td></tr></tbody></table><table-wrap-foot><fn><p>Anxiety disorder: one or more of panic disorder, generalized anxiety disorder, social phobia, and agoraphobia. IDS: inventory of depressive symptomatology. BAI: Beck anxiety inventory. GAD: generalized anxiety disorder. IDS categorical cutoffs: 0–13/14–25/26–38/39–48/49–84. BAI categorical cutoffs (<xref rid="bb0060" ref-type="bibr">Kabacoff et al., 1997</xref>): 0–9/10–18/19–29/30–63.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0005"><label>⁎</label><p id="np0005">At the time of scanning.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Sample characteristics for the NESDA (stratified by study site) and MOTAR samples.</div>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>NESDA 1</th><th>NESDA 2</th><th>NESDA 3</th><th>MOTAR</th><th>Total</th></tr></thead><tbody><tr><td>N</td><td>32</td><td>57</td><td>62</td><td>36</td><td>187</td></tr><tr><td>Age (SD)</td><td>36 (9.52)</td><td>37.26 (10.26)</td><td>35.87 (11.51)</td><td>36.69 (12.37)</td><td>36.48 (10.93)</td></tr><tr><td>N Female (%)</td><td>19 (59%)</td><td>39 (68%)</td><td>43 (69%)</td><td>23 (66%)</td><td>124 (66%)</td></tr><tr><td>N MDD (%) (no anx. disorder)</td><td>13 (40%)</td><td>18 (32%)</td><td>22 (35%)</td><td>10 (28%)</td><td>63 (34%)</td></tr><tr><td>N Anxiety disorder (%) (no MDD)</td><td>11 (34%)</td><td>13 (22%)</td><td>21 (34%)</td><td>2 (6%)</td><td>47 (25%)</td></tr><tr><td>N Comorbid (%)</td><td>8 (25%)</td><td>26 (45%)</td><td>19 (30%)</td><td>24 (67%)</td><td>77 (41%)</td></tr><tr><td>Current??? IDS (SD)</td><td>22.31 (9.66)</td><td>24.66 (11.45)</td><td>19.93 (12.42)</td><td>15.81 (10.56)</td><td>21.11 (11.96)</td></tr><tr><td>Current??? IDS categorical none/mild/moderate/severe/very severe</td><td>5/16/9/1/1</td><td>10/18/22/6/1</td><td>22/20/16/2/2</td><td>19/10/5/2/0</td><td>56/64/52/11/4</td></tr><tr><td>Current??? BAI (SD)</td><td>13.19 (8.45)</td><td>13.33 (9.73)</td><td>13.34 (9.35)</td><td>21.67 (11.95)</td><td>14.91 (10.34)</td></tr><tr><td>Current??? BAI categorical none/mild/moderate/severe</td><td>11/3/7/1</td><td>22/19/13/3</td><td>27/18/12/5</td><td>5/11/11/9</td><td>65/61/43/18</td></tr><tr><td>N in remission (IDS and BAI)</td><td>3 (9%)</td><td>10 (18%)</td><td>16 (25%)</td><td>5 (14%)</td><td>34 (18%)</td></tr><tr><td>Baseline antidepressant use</td><td>7 (21%)</td><td>20 (35%)</td><td>23 (37%)</td><td>0 (0%)</td><td>50 (26%)</td></tr><tr><td>Social phobia</td><td>12 (37%)</td><td>23 (40%)</td><td>23 (37%)</td><td>15 (42%)</td><td>73 (39%)</td></tr><tr><td>Panic with agoraphobia</td><td>6 (18%)</td><td>13 (22%)</td><td>17 (27%)</td><td>8 (22%)</td><td>44 (24%)</td></tr><tr><td>Panic without agoraphobia</td><td>4 (13%)</td><td>11 (19%)</td><td>9 (15%)</td><td>1 (3%)</td><td>25 (13%)</td></tr><tr><td>Agoraphobia</td><td>4 (13%)</td><td>3 (5%)</td><td>3 (5%)</td><td>0 (0%)</td><td>10 (5%)</td></tr><tr><td>GAD</td><td>7 (22%)</td><td>16 (28%)</td><td>15 (24%)</td><td>7 (19%)</td><td>45 (24%)</td></tr></tbody></table></div>Anxiety disorder: one or more of panic disorder, generalized anxiety disorder, social phobia, and agoraphobia. IDS: inventory of depressive symptomatology. BAI: Beck anxiety inventory. GAD: generalized anxiety disorder. IDS categorical cutoffs: 0–13/14–25/26–38/39–48/49–84. BAI categorical cutoffs (???): 0–9/10–18/19–29/30–63.⁎At the time of scanning.</transformed-table></extracted-table></extracted-tables-set>